Translational Aspects of Erythropoietin Receptor and Hypoxia-Inducible Factors in Breast Cancer
Författare
Summary, in English
EPOR has also been found in non-hematopoietic tissues and in tumors of various origins. We have evaluated EPOR expression in breast tumors from a clinical trial evaluating tamoxifen treatment versus no adjuvant treatment. We found that high EPOR expression correlates to impaired tamoxifen response in patients with estrogen receptor (ER) positive tumors. EPOR expression also correlated to survival in these patients. When further investigating EPOR function we found that EPOR knockdown impaired proliferation in ER positive, but not ER negative breast cancer cells, supposedly via modulating effects of ER activity. EPOR knockdown also improved tamoxifen response in ER positive breast cancer cells. These effects were not dependent on EPO. Our results suggest an EPO-independent but ER-dependent function of EPOR in breast cancer cells.
Hypoxia is a common feature of solid tumors and is believed to be a consequence of tumors outgrowing their vasculature. Tumor hypoxia is associated with a more aggressive phenotype and treatment resistance. The main regulators of the hypoxic response are the hypoxia-inducible factors (HIFs) 1 & 2. We have investigated HIF-1α and HIF-2α expression in breast cancer and found a correlation between HIF-2α expression and distant metastasis and impaired prognosis, suggesting that HIF-2α has an important role in tumor progression. We also show differential time and oxygen dependent regulation of the two different HIF-α subunits and differences in their contribution to inducing VEGF expression.
Avdelning/ar
- Institutionen för translationell medicin
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
Publiceringsår
2012
Språk
Engelska
Publikation/Tidskrift/Serie
Lund University Faculty of Medicine Doctoral Dissertation Series
Volym
2012:7
Fulltext
Dokumenttyp
Doktorsavhandling
Förlag
Center for Molecular Pathology, Faculty of Medicine
Ämne
- Cancer and Oncology
Nyckelord
- Breast Cancer
- Anemia
- Hypoxia
- Erythropoietin (EPO)
- EPO receptor (EPOR)
- Estrogen Receptor (ER)
- Hypoxia-Inducible Factors (HIFs)
- Tamoxifen Response
- Proliferation
Status
Published
Handledare
ISBN/ISSN/Övrigt
- ISSN: 1652-8220
- ISBN: 978-91-86871-69-7
Försvarsdatum
3 februari 2012
Försvarstid
09:15
Försvarsplats
Main Lecture Hall, Department of Pathology, Skåne University Hospital, Malmö
Opponent
- Jens Overgaard (Professor)